In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...
Two New Analyses from SEQUOIA-HCM Demonstrate Treatment with Aficamten Improves Post-Exercise Oxygen Uptake Recovery and Quality of LifeNew Data ...